Lipocine SG&A Expense (Quarterly) Analysis

Lipocine Inc (LPCN)

4.57 +0.13 (+2.93%) USD | NASDAQ | Apr 25, 16:00

4.57 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	1.135M
September 30, 2023	1.043M
June 30, 2023	1.440M
March 31, 2023	1.287M
December 31, 2022	0.8903M
September 30, 2022	0.7989M
June 30, 2022	1.130M
March 31, 2022	1.244M
December 31, 2021	1.048M
September 30, 2021	1.222M
June 30, 2021	1.526M
March 31, 2021	1.534M
December 31, 2020	2.322M
September 30, 2020	1.887M
June 30, 2020	1.954M
March 31, 2020	2.085M
December 31, 2019	1.607M
September 30, 2019	1.427M
June 30, 2019	1.386M
March 31, 2019	1.176M
December 31, 2018	0.9895M
September 30, 2018	0.9301M
June 30, 2018	1.682M
March 31, 2018	1.688M

Date	Value
December 31, 2017	3.635M
September 30, 2017	2.720M
June 30, 2017	2.034M
March 31, 2017	1.825M
December 31, 2016	1.343M
September 30, 2016	1.394M
June 30, 2016	3.247M
March 31, 2016	4.397M
December 31, 2015	1.930M
September 30, 2015	1.700M
June 30, 2015	1.116M
March 31, 2015	1.056M
December 31, 2014	1.170M
September 30, 2014	0.8718M
June 30, 2014	1.036M
March 31, 2014	1.924M
December 31, 2013	1.034M
September 30, 2013	1.182M
June 30, 2013	0.0031M
March 31, 2013	0.0032M
December 31, 2012	-1.181M
September 30, 2012	0.4672M
June 30, 2012	0.0609M
March 31, 2012	0.0044M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.7989M

Minimum

Sep 2022

2.322M

Maximum

Dec 2020

1.419M

Average

1.386M

Median

Jun 2019

SG&A Expense (Quarterly) Benchmarks